These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 14053804)
41. TOPICAL FLUOCINOLONE WITH OCCLUSION IN PRETIBIAL MYXEDEMA. JONES BE; WILLIAMS RM Arch Dermatol; 1964 Sep; 90():305-6. PubMed ID: 14170604 [No Abstract] [Full Text] [Related]
42. Psoriasis treated with tropical fluocinolone acetonide and occlusive dressings. STEVENSON CJ; WHITTINGHAM GE Br Med J; 1963 Jun; 1(5343):1450-1. PubMed ID: 13984050 [No Abstract] [Full Text] [Related]
43. [Fluocinolone acetonide in the local treatment of eczema, psoriasis and discoid lupus erythematosus]. BJORNBERG A; HELLGREN L Sven Lakartidn; 1963 May; 60():1333-8. PubMed ID: 13971324 [No Abstract] [Full Text] [Related]
44. [EXPERIENCES WITH THE LOCAL CORTICOSTEROID, FLUOCINOLONE ACETONIDE]. SCHNYDER UW Schweiz Med Wochenschr; 1964 Dec; 94():1762-5. PubMed ID: 14335017 [No Abstract] [Full Text] [Related]
45. Fluocinolone acetonide--a new steroid with an antipsoriatic effect. BJORNBERG A; HELLGREN L Acta Derm Venereol; 1963; 43():158-62. PubMed ID: 13971328 [No Abstract] [Full Text] [Related]
46. Relative potency of percutaneously absorbed corticosteroids in the suppression of pituitary-adrenal function. Scoggins RB; Kliman B J Invest Dermatol; 1965 Nov; 45(5):347-55. PubMed ID: 5321337 [No Abstract] [Full Text] [Related]
47. [Clinical experiences with fluocinolone in local treatment of psoriasis vulgaris]. BENDER E; ZIERZ P; RASP KF Med Welt; 1962 Nov; 47():2508-13. PubMed ID: 13967332 [No Abstract] [Full Text] [Related]
48. [FLUOCINOLONE ACETONIDE (0.01 PER CENT) UNDER OCCLUSIVE DRESSING: THERAPEUTIC VALUE IN DERMATOLOGY OF THIS NEW PRODUCT IN WEAK CONCENTRATION]. BAZEX A; DUPRE A; CHRISTOL B Presse Med (1893); 1964 Oct; 72():2387-8. PubMed ID: 14187775 [No Abstract] [Full Text] [Related]
49. [FLUOCINOLONE IN DERMATOLOGY]. CORDERO AA Prensa Med Argent; 1963 Apr; 50():1077-80. PubMed ID: 14089188 [No Abstract] [Full Text] [Related]
50. Eccrine function during therapy of psoriasis. Paradoxical sweating on and around psoriatic lesions during tropical therapy by fluocinolone acetonide and plastic films. BUCK HW; MITCHELL JC Arch Dermatol; 1963 Jun; 87():696-700. PubMed ID: 14016549 [No Abstract] [Full Text] [Related]
51. [Quality control of prepared drug forms containing corticosteroids by physicochemical means. II. Spectrophotmetric determination of prednisolone and fluocinolone acetonide in ointments]. Bobkova LN; Kazarinov NA Farm Zh; 1974; (1):59-63. PubMed ID: 4463033 [No Abstract] [Full Text] [Related]
57. Comparison of topical fluocinolone and tumenol prednisolone: a double-blind trial. Stahle IO; Webb JG Med J Aust; 1965 Sep; 2(10):418-20. PubMed ID: 5318272 [No Abstract] [Full Text] [Related]
58. Diprosone ointment in psoriasis. A double-blind trial. Ross CM S Afr Med J; 1974 Oct; 48(48):2030-2. PubMed ID: 4612753 [No Abstract] [Full Text] [Related]
59. Comparison of steroids in topical treatment of psoriasis. Groth O; Juhlin L; Michaƫlsson G; Ohman S Acta Derm Venereol; 1967; 47(4):216-21. PubMed ID: 4166056 [No Abstract] [Full Text] [Related]